Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immunological Impact of Adding Hydroxychloroquine in Patients With Discordant CD4+ Cell Responses to Suppressive HAART: A Phase I Pilot Study.

NCT01232660 is registered in ClinicalTrials.gov with St Stephens Aids Trust as lead sponsor.

NCT NCT01232660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01232660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immunological Impact of Adding Hydroxychloroquine in Patients With Discordant CD4+ Cell Responses to Suppressive HAART: A Phase I Pilot Study.
Lead sponsor
St Stephens Aids Trust
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2010
Completion date
August 31, 2014
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection